ReviewFrontiers in oncology2026

Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023-2026 evidence and a proposed clinical integration framework.

Ashish Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.